MITCHELL GUANZON: Open Payments
NPI 1992288278 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$732 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $238 · 2025 $732
Food & beverage: $732
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $340 |
| Axsome Therapeutics, Inc. | 1 | $123 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $114 |
| ABBVIE INC. | 1 | $83 |
| Otsuka America Pharmaceutical, Inc. | 1 | $73 |
Products named: Wegovy, Auvelity, Ozempic, NEFFY, QULIPTA, REXULTI.
Industry payments across FL — which companies pay providers there.
